NCT02720328View on ClinicalTrials.gov

Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants

PHASE4CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 31, 2016

Conditions

Embolism and ThrombosisHemorrhage

Interventions

BIOLOGICAL

Blood samples for DOAC measurement

Trial Locations (2)

1200

Cliniques Universitaires Saint-Luc, Brussels

5530

CHU UCL Namur site Godinne, Yvoir

All Listed Sponsors

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT02720328 - Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants | Biotech Hunter | Biotech Hunter